PIPC Chairman Tony Coelho
|
In a January 4 Health Affairs Forefront article, “Options for CMS Drug Price Negotiations,” Daniel Ollendorf and Dominic Voehler discuss pricing methodologies based on how much a drug improves health. However, the authors overemphasize reliance on frameworks that, especially for people with disabilities, are red flags due to their reliance on valuing people’s lives in dollars. Instead, the Centers for Medicare and Medicaid Services (CMS) has an opportunity to achieve a level of patient-centeredness that other programs lack.
|
|
For Immediate Release
March 23, 2023 PIPC Chairman Tony Coelho issued the following statement on H.R. 485, the Protecting Health Care for All Patients Act.  This blog was adapted from testimony delivered by PIPC Chairman Tony Coelho to Oregon's Health Evidence Review Commission (HERC) on November 17, 2022.
Thank you for allowing me to testify again today. I want to start by saying I appreciate that the commission chose not to vote today on a policy to use the quality-adjusted life year. Chairman's Corner: Aligning Health Technology Assessment with Efforts to Advance Health Equity11/13/2022
As Chairman of the Partnership to Improve Patient Care (PIPC), I could not be more pleased to see the widespread emphasis among health stakeholders on advancing health equity. As stated by the Centers for Disease Control, racism is a public health crisis. It will take all facets of the health care system to address the effects of stigma and discrimination on health and access to health care.
On October 6, PIPC Chair Tony Coelho testified in response to the Oregon Health Evidence Review Committee's proposed options for continuing its use of the discriminatory quality-adjusted-life-years metric. Chairman's Corner: A Step Backward — No Voice for Stakeholders in Updated Reconciliation Provisions7/14/2022
Chairman's Corner: Don’t Let Payer Investments in QALYs Undermine California’s Health Equity Goals6/21/2022
This op-ed originally appeared in Morning Consult on November 23, 2021
This op-ed originally appeared in The Hill on September 14, 2021
As Chairman of the Partnership to Improve Patient Care (PIPC), I want to express my sincere congratulations to President-elect Joe Biden. Patients and people with disabilities are eager and excited to work with the President-elect and his team on policies that will improve their health and quality of life.
Is the life of a person with a disability or chronic condition less valuable than the life of a person without one? There is renewed interest among lawmakers to tackle healthcare costs, specifically, the rising cost of prescription drugs. However, the Administration’s proposed International Pricing Index (IPI) model, an initiative proposed in 2018 that would arbitrarily base prices of American medications off the government set prices of medications in foreign countries, is deeply flawed. Yet, we may see some version of it reintroduced soon.
Chairman's Corner: New York’s Embrace of Discriminatory Value Assessments is a Call to Action!4/4/2019
 The final New York budget is complete. And now we know for sure that states feel empowered by this administration to discriminate in their Medicaid programs. I had hoped that we were past these tactics to discriminate when, in 1992, HHS denied a state Medicaid waiver using quality-adjusted-life-years (QALYs) to determine its coverage because of its implications for violating the Americans with Disabilities Act (ADA) and when, in 2010, Congress banned use of QALYs in Medicare. But it looks like we are fighting this kind of discrimination state-by-state now.
|
